Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8680301 | Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring | 2018 | 11 Pages |
Abstract
The SOMI model provides an efficient approach for clinical trial cognitive screening in advance of more costly biomarker studies and ultimately in clinical practice, and provides a vocabulary for understanding AD biomarker patterns and for re-analysis of existing clinical trial data.
Keywords
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Ellen Grober, Amy E. Veroff, Richard B. Lipton,